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ABSTRACT
miR-21 is the most commonly over-expressed
microRNA (miRNA) in cancer and a proven
oncogene. Hsa-miR-21 is located on chromosome
17q23.2, immediately downstream of the vacu-
ole membrane protein-1 (VMP1) gene, also known
as TMEM49. VMP1 transcripts initiate 130kb
upstream of miR-21, are spliced, and polyadeny-
lated only a few hundred base pairs upstream of
the miR-21 hairpin. On the other hand, primary
miR-21 transcripts (pri-miR-21) originate within the
last introns of VMP1, but bypass VMP1 polya-
denylation signals to include the miR-21 hairpin.
Here, we report that VMP1 transcripts can also by-
pass these polyadenylation signals to include
miR-21, thus providing a novel and independ-
ently regulated source of miR-21, termed VMP1–
miR-21. Northern blotting, gene-specific RT-PCR,
RNA pull-down and DNA branching assays support
that VMP1–miR-21 is expressed at significant levels
in a number of cancer cell lines and that it is pro-
cessed by the Microprocessor complex to pro-
duce mature miR-21. VMP1 and pri-miR-21 are
induced by common stimuli, such as phorbol-
12-myristate-13-acetate (PMA) and andro-
gens, but show differential responses to some
stimuli such as epigenetic modifying agents.
Collectively, these results indicate that miR-21 is a
unique miRNA capable of being regulated by alter-
native polyadenylation and two independent gene
promoters.
INTRODUCTION
Mature microRNAs (miRNAs) are short endogenous
non-coding RNAs that post-transcriptionally inhibit the
expression of target genes (1,2). miRNAs are initially
expressed within long transcripts known as primary
microRNAs (pri-miRNAs). Many pri-miRNAs are also
protein-coding (3), thus they are processed both as
pri-miRNAs and as pre-mRNAs, including 50-capping,
splicing and polyadenylation. For miRNA processing
the stem–loop intermediate, or pre-miRNA, is released
from the nascent transcript by the Microprocessor
complex (4,5), which minimally consists of DGCR8 and
Drosha. DGCR8 acts as a molecular anchor to measure
the distance from the dsRNA–ssRNA junction and guide
the RNase III enzyme, Drosha, for cleavage to release the
pre-miRNA (6). Current knowledge supports that release
of pre-miRNAs occurs co-transcriptionally, along with
pre-mRNA processing events, before the transcript
is discharged from the DNA template (7). The unleashed
pre-miRNA is subsequently transported to the cytoplasm
by Exportin-5 and further cleaved by Dicer to gener-
ate the mature miRNA. Once incorporated into the
RNA-induced silencing complex, the single-stranded
mature miRNA will target mRNAs by complete or
partial sequence complementary, resulting in message de-
stabilization and decreased translation (8).
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The current estimate for human miRNAs hairpin pre-
cursors is 1527 (9,10). Their rate of discovery has
increased signiﬁcantly with second and third-generation
sequencing technologies (11); however, the pri-miRNAs
which encode them and their transcription start sites
(TSSs) remain poorly characterized. One of the ﬁrst
characterized pri-miRNAs was miR-21 (12). Interestingly
miR-21 belongs to a rare class of miRNAs by being
located near the 30-untranslated region (30-UTR) of a
coding gene. Speciﬁcally, miR-21 is located immediately
downstream of the vacuole membrane protein-1 (VMP1)
gene, also known as TMEM49. However, the VMP1 tran-
script is polyadenylated prior to the miR-21 hairpin and
thus was not thought to contribute to its expression
(13,14). Instead, the primary miR-21 transcript was
found to initiate within intron 11 of VMP1, resulting in
a 3.4 kb capped, polyadenylated and unspliced transcript
(12). Subsequent alternative isoforms and TSSs were
detected upstream of this initial location, namely within
intron 10 of VMP1, to generate an unspliced 4.3 kb pri-
miR-21 transcript (15). This larger transcript was con-
ﬁrmed by northern blotting and a putative miR-21
promoter, miPPR-21, was characterized and veriﬁed
(15,16). Additional miR-21 promoters and primary tran-
scripts have been characterized from within the terminal
intronic regions of VMP1 (17,18). Therefore, the full com-
plement of miR-21-encoding transcripts is complex and
has yet to be fully characterized.
miR-21, as measured by the mature miRNA, is the most
commonly elevated miRNA in cancer (19). There are
many mechanisms associated with elevated miR-21
levels. The encoding genetic locus, 17q23, is ampliﬁed in
many solid tumors (20–22). In addition, miR-21 expres-
sion is stimulated by a variety of cancer associated
pathways such as hypoxia, inﬂammation, AP-1 and
steroid hormones (15–17,23,24). Elevated miR-21 expres-
sion results in enhanced growth and reduced apoptosis in
a number of cell culture and animal models. Importantly,
elevated miR-21 alone was shown to be sufﬁcient to
induce a pre-B malignant lymphoid-like phenotype in
animal models and continuous miR-21 expression was ne-
cessary to maintain the tumor phenotype, indicating that
miR-21 is a true oncogene (25). Similarly, miR-21 deletion
in mouse cancer models reduced tumor formation (26,27).
Thus, there is signiﬁcant evidence that miR-21 is an
important gene in cancer biology.
Detailed analysis of the miPPR-21 promoter identiﬁed
speciﬁc transcription factor binding sites, such as AP-1,
Ets/PU.1, C/EBP-a, STAT3, and others (28). Phorbol-
12-myristate-13-acetate (PMA), a known stimulant of
AP-1 transcription factors, was found to induce the
miPPR-21 promoter and the resulting 4.3 kb pri-miR-21
transcript, but not the overlapping VMP1 transcript (15).
Similar studies have reported disparate responses of
VMP1 and miR-21 following stimulation, indicating that
these two overlapping genes are independently regulated
(12,15,17,29). Expressed sequence taq (EST) database
analysis further suggests that these two genes are inde-
pendent, and that VMP1 mRNA does not extend into
the miR-21 hairpin. However, the overlapping nature
of VMP1 and miR-21 and their processing by
polyadenylation and Microprocessor cleavage has made
it difﬁcult to conﬁrm this autonomy. Here, we have
applied precise detection, sizing and capture techniques
to identify and characterize an alternatively poly-
adenylated isoform of VMP1, VMP1–miR-21, that initi-
ates from the coding VMP1 gene and extends the 30-UTR
to include the miR-21 hairpin. VMP1–miR-21 is
commonly expressed in many cell lines and is processed
by Drosha, suggesting that it is a true primary miR-21
transcript. These new data indicate that miR-21 is a
unique miRNA that is regulated both by alternative pol-
yadenylation and multiple independent promoters.
MATERIALS AND METHODS
Cell culture and siRNA transfection
Cells were grown using the American type culture
collection (ATCC) recommended media in the presence
of 10 mg/ml ciproﬂoxacin hydrochloride (US Biological)
and 10% fetal bovine serum. Drosha siRNA (23)
designed to anneal to Drosha mRNA at 50-AAGGACC
AAGUAUUCAGCAAG-30 was synthesized by Thermo
Scientiﬁc. Control non-target siRNA #1 (Dharmacon)
was also applied. Hiperfect reagent (Qiagen) was used to
transfect 20 nM of siRNAs according to the manufacturer
protocol.
RNA extraction and northern blotting
Total RNA was extracted from cells at 80% conﬂuency
with TRIzol reagent (Invitrogen). About 10–20 mg of
RNA was separated by 1.2% agarose denaturing gel and
northern blotting completed as previously described (30).
Transcript size was estimated relative to High Range
ssRNA Ladder (New England Biolabs). Primers and
northern blotting probes (Supplementary Table SI) were
generated from Michigan cancer foundation-7 (MCF-7)
cDNA PCR ampliﬁed using the GoTaq qPCR Master
Mix (Promega), single bands isolated by QIAquick PCR
Puriﬁcation Kit (Qiagen) and probes labeling by
a-32P-dCTP (Perkin Elmer) and ChromaSpin+TE-10
Columns (Clontech). After an ON incubation in
Ultrahyb Oligo Buffer (Ambion), blots were washed in
serial dilutions of hot 2SSC buffer and 2 SSC
buffer+0.5%SDS. Radioactive signals were directly
quantiﬁed using an Instant Image.
Reverse transcription and RT-PCR
One microgram of total RNA was subjected to random
reverse transcription using the QuantiTect Reverse
Transcription Kit (Qiagen). For gene-speciﬁc RT-PCR,
gene-speciﬁc primers (GSP) for reverse transcription
(Supplementary Table SII) were applied, with DNase
I Ampliﬁcation Grade (Invitrogen) digestion per 5 mg
total RNA. Two microgram GSP was applied with
ThermoScritpTM Reverse Transcriptase (Invitrogen)
according to the manufacturer protocol. As a control for
this step, a sample without reverse transcriptase was pro-
cessed in parallel. Following RNase H (Invitrogen) diges-
tion, cDNA was ampliﬁed by PCR using Power SYBR
6822 Nucleic Acids Research, 2012, Vol. 40, No. 14
 at Lleida Etsea Lib - U
54 on D
ecem
ber 11, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Green Mix (Applied Biosystems) and the speciﬁc primers
(Supplementary Table SI).
RNA pull-down
Fifty microgram of TRIzol-extracted total RNA was
applied to the mMACS Streptavidin Kit (Miltenyi Biotec
Inc.) following the manufacturer protocol. Heat-
denatured RNA and 0.5 mg of biotinylated capture DNA
probe (Supplementary Table SII) was annealed and mixed
with 100ml of mMACS Streptavidin Microbead, vortexed
and incubated for 2min. Beads were magnetically
captured, washed and speciﬁc transcripts eluted in pre-
heated RNAse-free water. Ten microliters was applied
for RT-PCR.
Mature miR-21 quantiﬁcation
TaqMan MicroRNA RT Kit (Applied Biosystems) was
used in combination with the miR-21-speciﬁc reverse tran-
scription primers followed by PCR using miR-21 TaqMan
speciﬁc primers and TaqMan 2X Universal PCR Master
Mix, No AmpErase UNG (Applied Biosystems). RNU6B
was used as normalization control.
30-Rapid ampliﬁcation of cDNA ends
GeneRacer Kit (Invitrogen) was applied to 5 mg of total
RNA from Drosha depleted MCF-7 following the manu-
facturer protocol. Oligo-ligated RNA was reverse
transcribed using the SuperScript III module and oligo-
dT primers. The 30-rapid ampliﬁcation of cDNA ends
(RACE)-ready cDNA was PCR ampliﬁed using the
Phusion High-Fidelity PCR Master Mix (Finnzymes).
Single products were PCR puriﬁed with QIAquick Gel
Extraction Kit (Qiagen) and cloned using the TOPO TA
Cloning Kit (Invitrogen). Plasmid DNA from insert-
positive colonies (white–blue screening) was extracted
with QIAPrep Spin Miniprep Kit (Qiagen) and sequenced.
Drosha QuantiGene branched-chain DNA assay
VMP1–miR-21 and pri-miR-21 levels were measured
using the branched-chain DNA (bDNA) assay described
elsewhere (31). DU-145 cells were transfected for 48 h with
Drosha siRNA or non-target siRNA #1 and Drosha
knock-down veriﬁed by RT-PCR. The QuantiGene
Screen Assay Kit 2.0 (Panomics) was used to speciﬁc-
ally capture the miR-21 containing transcripts
(chr17:55 273 238–55 273 669) to a 96-well plate during a
55C overnight incubation. Unbound material was
washed for three times, blocked and labeling probes
targeting RNA regions in intron 11 (chr17:55 271 009–
55 271 910, speciﬁc for pri-miR-21) or alternatively exons
2–5 of VMP1 (bases 125–538 of VMP1–miR-21) were
added. Signal ampliﬁer molecules were added, washed
and luminescent substrate added for quantiﬁcation in a
microplate luminometer. A ‘no-template’ background
provided the background values for each set of probes.
Values were normalized to an identical QuantiGene
assay for the housekeeping gene cyclophylin B.
Transcriptional induction
For transcription initiation studies, HL-60 cultures were
treated for 6 h with 160 nM of PMA (Sigma) or vehicle
(DMSO). HCT116 and HEK293 cells were seeded at 20%
conﬂuence in p35 mm plates. After 24 h, 5-aza-20-
deoxycytidine (Fluka) or MS-275 (Syndax) were added
to the media at a ﬁnal concentration of 10 and 1 mM,
respectively. As a control, equivalent amounts of vehicle
were used. Media and treatment were refreshed every 48 h.
Additional Supplementary Methods can be found at
Nucleic Acids Research online.
RESULTS
Identiﬁcation of a VMP1–miR-21 fusion transcript
The precursor miR-21 hairpin is located immediately
downstream of the VMP1 coding gene on chromosome
17q23 (Figure 1). Despite their close proximity, previous
studies indicate that VMP1 and primary miR-21 tran-
scripts are regulated by independent promoters and that
VMP1 transcripts are polyadenylated prior to miR-21
(12–15,18). We hypothesized that alternative pol-
yadenylation of VMP1 may occur at some rate to
produce a read-through VMP1–miR-21 fusion transcript.
To investigate this, an androgen receptor (AR) induction
model was applied (16,23). Cells were treated with the syn-
thetic androgen, R1881, and changes in VMP1 transcript
levels were measured by quantitative RT-PCR. In all four
AR-positive prostate cancer cell lines studied, androgen
treatment induced VMP1 gene expression
(Supplementary Figure S1A). Using these cells, an
RT-PCR strategy was applied to detect the putative
VMP1–miR-21 fusion transcript by amplifying a region
starting upstream of the reported pri-miR-21 TSSs,
within VMP1 exon 9, to a region downstream of the
miR-21 hairpin. Cells were ﬁrst pre-treated with Drosha
siRNA, to reduce hairpin processing. Indeed, a VMP1–
miR-21 amplicon was detected in LNCaP and LAPC-4
cells and veriﬁed by sequencing (Supplementary Figure
S1B). VMP1 expression levels were then quantiﬁed in a
panel of prostate cancer cell lines and compared to a
mixture of healthy prostate from young men. MCF-7
cells, which are known to express high levels of miR-21,
were included as a positive control. All tumor cell lines
exhibited greater levels of VMP1 than the normal prostate
of young men (Supplementary Figure S2). These results
support that VMP1 is expressed in cancer cell lines and
that alternative polyadenylation events can lead to the in-
clusion of the miR-21 hairpin within the VMP1 transcript.
Using these and other cancer cells lines, northern
blotting was applied to characterize pri-miR-21 and
VMP1 transcripts. Drosha knockdown was performed as
above to diminish miR-21 transcript processing. A series of
probes were designed to differentially detect the VMP1,
pri-miR-21, VMP1–miR-21 transcripts and their cleavage
products (Figure 2A). Because of the overlapping nature of
these transcripts, some probes detect multiple products.
Probe P1 binds to a region spanning from the last
poly(A) of VMP1 to 180 bp downstream of the miR-21
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hairpin. Therefore, it should detect the non-spliced 4.3 kb
pri-miR-21 transcript (band ‘a’) as well as the putative
spliced, 2.5 kb VMP1–miR-21 transcript (band ‘b’), but
not the polyadenylated VMP1 (band ‘c’). Results show
that the highest miR-21 expressing cell lines, MCF-7 and
DU-145, express both pri-miR-21 and VMP1–miR-21
transcripts (Figure 2B, bands ‘a’ and ‘b’). Of note,
HEK293 cells are known to express low levels of miR-21
and accordingly exhibit undetectable levels of pri-miR-21
and VMP1–miR-21 by probe P1 in Figure 2B. However,
the VMP1 transcripts (band ‘b+c’) were visible in HEK293
cells with probes P3 and P4. The combination of an absent
‘band b’ with probe P1 in HEK293 and the presence of a
‘band b+c’ with probes P3 and P4 demonstrate the speciﬁ-
city of the northern blots and conﬁrm the common expres-
sion of an alternatively polyadenylated VMP1 transcript,
VMP1–miR-21. In all of the other cancer cell lines tested,
pri-miR-21 was detected by probes P1 (miR-21 hairpin
region), P2 (VMP1 intron 11) and P4 (VMP1 exon 12).
Similarly, in all cell lines, VMP1 (band ‘c’) was detected
by probes P3 and P4; however, the observed size of
VMP1–miR-21 (probe P1, band ‘b’) was indistinguishable
from VMP1 (probes P3 and P4, band ‘c’). The comparison
of the bands detected with these probes suggests that not all
VMP1 encompassed miR-21. This is particularly clear
when observing HCT116, HeLa and HEK293 cells which
express VMP1 (probes P3 and P4) with undetectable levels
of VMP1–miR-21 (probe P1). It is possible that cell-speciﬁc
alternative polyadenylation determines VMP1–miR-21
expression rates.
To further verify and characterize VMP1–miR-21
transcripts, two separate miR-21 primary RNA enrich-
ment techniques were applied. In one technique, miR-21-
speciﬁc RNA pull-down was achieved with a biotinylated
oligonucleotide complementary to a region between the
miR-21 hairpin and VMP1 polyadenylation [poly(A)]
signals (Supplementary Figure S3, Oligo #1). Captured
RNA was then reverse transcribed with random primers
to generate cDNA. The second enrichment technique
utilized reverse transcription by a GSP, located immedi-
ately downstream of the miR-21 hairpin (Supplementary
Figure S3, Oligo #2). The resulting cDNA from both
enrichment protocols was then applied to quantitative
PCR (qPCR) for VMP1–miR-21 (exons 10-11), pri-miR-
21 (intron 11) or both transcripts (exon 12). Both
approaches were veriﬁed to enrich for miR-21 primary
transcripts or deplete non-speciﬁc products, respectively
(Figure 3A and B). As shown in Figure 3C, miR-21
RNA pull-down captured VMP1–miR-21 transcripts
(exons 10-11) in DU-145 and HL-60 cell, as well as
pri-miR-21 (intron 11). Similarly, in Figure 3D,
miR-21-speciﬁc reverse transcription detected VMP1–
miR-21 (exons 10-11) and pri-miR-21 (intron 11) in
MCF-7 cells. Collectively, these studies conﬁrm the
northern blots and support the common expression of
VMP1–miR-21 in multiple cell types.
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Figure 1. VMP1 and miR-21. Structure of the VMP1 and miR-21 loci at chromosome 17q23. Scale is indicated. VMP1 exon numbers are noted.
Inset highlights the pri-miR-21 gene region. White numbers identify exons 11 and 12 of VMP1. The line of intermediate thickness indicates the
30-UTR of VMP1. A gray arrow is situated at the miR-21 promoter, miPPR-21. The red hairpin indicates the location of the pre-miR-21 hairpin.
The black arrow represents the TSS of VMP1. Evolutionary conservation (UCSC Genome Browser 28 species conservation track, NCBI36/hg18
assembly) is plotted below.
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Figure 2. VMP1 and pri-miR-21 transcripts by northern blotting. (A) Schematic of the transcripts VMP1, VMP1–miR-21 and pri-miR-21 (not to
scale). Horizontal gray arrows represent exons and black lines represent introns (numbered in red) and non-coding sequences. Break symbols (double
slash mark) are placed between exons 1 and 8 of VMP1 and VMP1–miR-21. Splicing is indicated by inverted triangles and Drosha cleavage by
diagonal arrows. Pri-miR-21 is not spliced and therefore does not include exon or splicing symbols. Processed transcripts are marked by dashed lines.
Polyadenylation signals are indicated as pA. Northern probes P1, P2, P3, P4 and P5 are drawn at the site of hybridization along the bottom of the
transcripts. (B) Northern blot analysis of total RNA from cells transfected for 48 h with Drosha siRNA (siDrosha,+) or a non-target control siRNA
(). On the left, probes applied for each northern blot and corresponding bands (a–c) are indicated. Molecular size ladder is represented on the right
of the panels.
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Characterization of VMP1–miR-21 and pri-miR-21
30-termini
The UCSC Genome Browser poly(A) track identiﬁes
four poly(A) signals at the 30-end of VMP1 (Figure 4B).
Three are upstream of the miR-21 hairpin as mapped by
cDNA/EST sequences, and another is downstream and
predicted using bioinformatics (32). In addition, the 30-
end of the mapped pri-miR-21 transcript (BC053563) ter-
minates several hundred base pairs downstream of the
most distal poly(A) signal (Figure 4A). To further charac-
terize the 30-termini of miR-21 transcripts we performed
30-RACE. Figure 4C summarizes that two termini were
identiﬁed, both near canonical AAUAAA poly(A)
signals. One is proximal and consistent with the previously
predicted poly(A) signal and the second is a novel distal
site near the BC053562 terminus. Both poly(A) signals are
in highly conserved regions (Figure 4D). A northern probe
(P5), which hybridizes to the region between the two
poly(A) sites, was generated to identify transcripts which
use the most distal poly(A) signal (Figure 2A). Probe P5
detected the 4.3 kb pri-miR-21 (band ‘a’) in Drosha
knocked-down cells, and also detected an 1 kb band con-
sistent with the 30-fragment of Drosha-cleaved pri-miR-21
(Figure 2B, band ‘a2’). As would be expected, the intensity
of the 30-cleavage product (fragment ‘a2’), is reduced with
Drosha knock-down. If VMP1–miR-21 also utilized the
distal poly(A) site, the predicted size would be 1 kb
greater than VMP1 itself, or 3.6 kb. However no band
with a compatible size was observed on northern
blotting with probes P1 or P5 (Figure 2B), indicating
that VMP1–miR-21 primarily utilizes the proximal
signal. This is supported by the small fragment
(Figure 2A, band ‘b2’), which is visible on higher percent-
age gels with probe P1 (Supplementary Figure S4).
Collectively, these results indicate that VMP1–miR-21
consistently utilizes the proximal poly(A) signal and
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pulled-down (RNA pull-down) with a biotinylated probe in the miR-21 hairpin region and control or miR-21-speciﬁc RNA was quantiﬁed by
quantitative RT-PCR. The y-axis represents log fold enrichment after miR-21 pull down, relative to input RNA. (B) Total RNA from MCF-7 cells
was reverse transcribed using a miR-21 GSP. The resulting cDNA was quantiﬁed by qPCR for control or miR-21 transcripts to determine enrich-
ment by GSP reverse transcription. (C) RNA from miR-21 pull down in DU-145 and HL-60 cells was reverse transcribed and amplicons speciﬁc for
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pri-miR-21 the distal poly(A) signal (sites 1 and 2, respect-
ively, in Figure 4C).
Drosha processing of primary miR-21 transcripts
miRNAs are rarely located in the 30-UTR of coding tran-
scripts. This could be because Microprocessor cleavage
would de-stabilize such messages by leaving a free and
non-polyadenylated 30-end (12). VMP1–miR-21 provides
a novel endogenous gene to study this phenomenon. To
investigate effects of Drosha cleavage on VMP1 mRNA
levels, Drosha was knocked-down by siRNA treatment
and validated by quantitative RT-PCR (Figure 5,
Drosha). In this setting, levels of VMP1 mRNA showed
a cumulative increase, irrespective of the cell line
(Figure 5, VMP1). We explored whether this increase
was due to Drosha-regulated de-stabilization of the
mRNA or Drosha-mediated effects on transcriptional
processing by repeating this experiment in the presence
or absence of the transcriptional inhibitor Actinomycin
D (Supplementary Figure S6). In MCF-7 cells, which
express high levels of VMP1–miR-21, Drosha knock-
down stabilized the existing VMP1 transcripts in the
presence and absence of Actinomycin D. On the other
hand, in LAPC4 cells, VMP1 levels were not induced in
the absence of new transcription. These results suggest
that Microprocessor activity reduces the levels of VMP1
transcripts through both mRNA de-stabilization and tran-
scriptional processing.
To determine the efﬁciency of Drosha processing of the
two miR-21 primary transcripts, RNA quantiﬁcation with
branched DNA (bDNA) technology was applied (31).
Brieﬂy, total RNA was puriﬁed from Drosha or control
depleted DU-145 cells. Transcripts containing the miR-21
hairpin were then captured to a plate using multiple
probes within the vicinity of the miRNA hairpin. Probes
targeting VMP1–miR-21 (exons 2–5) or pri-miR-21
(intron 11) were then used to differentiate the amounts
of the two miR-21 primary transcripts in the control or
Drosha knocked-down states. Because Microprocessor
cleavage would separate the captured and probed
regions, only unprocessed transcripts should be detected.
Drosha knock-down resulted in an increase both VMP1–
miR-21 and pri-miR-21 levels, indicating that both
transcripts are substrates of the Microprocessor complex
(Figure 6A). Interestingly, pri-miR-21 appears to be more
signiﬁcantly affected by Drosha depletion. To further
study Microprocessor processing rates, pri-miR21 and
VMP1–miR-21 Drosha cleavage products were quantiﬁed
fromMCF-7 cell northern blots (Figure 6B). In these cells,
VMP1–miR-21 transcripts appear to be more signiﬁcantly
affected by Drosha knock-down. Both studies support
that the novel VMP1–miR-21 transcript is a substrate
for Drosha cleavage and that it is processed with compar-
able efﬁciency to the pri-miR-21 transcript.
Common and differential transcriptional regulation of
pri-miR-21 and VMP1
It has been previously reported that mature miR-21
expression is induced by the AP-1 stimulating agent,
PMA (15,33). To conﬁrm this, RNA from HL-60 cells
was treated with PMA or vehicle for 6 h and analyzed
by northern blotting with probes that detect the miR-21
hairpin region (probe P1) as well as VMP1 and VMP1–
miR-21 transcripts (probe P3). As expected, bands
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corresponding to the pri-miR-21 transcript were signiﬁ-
cantly increased following PMA treatment (Figure 7A,
probe P1 and band ‘a1’). Interestingly, VMP1–miR-21
and VMP1 transcripts were similarly stimulated by AP-1
activation (Figure 7A, probes P1 and P3, bands ‘b’ and ‘c’,
respectively). This was conﬁrmed by quantitative RT-PCR
(Figure 7B). Based on these ﬁndings, we anticipate that a
portion of PMA-stimulated mature miR-21 is generated
Figure 5. Drosha knock-down enhances VMP1 transcript levels. Total RNA was prepared from (A) LNCaP, (B) MCF-7 or (C) LAPC-4 cells, which
had been transfected for 72 h with a negative control siRNA (siNeg) or Drosha siRNA (siDrosha). Expression of Drosha and VMP1, relative to
actin, was measured by quantitative RT-PCR. Quantiﬁcation is the result of three independent measurements. *P< 0.05; **P< 0.005; ***P< 0.001
(Student’s t-test).
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quantiﬁed for relative pri-miR-21 (band a2) and VMP1–miR-21 (band b2) cleavage products after treatment with control or Drosha siRNA, and
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through VMP1–miR-21 transcripts. These results slightly
differ from a previous study where PMA was not found to
stimulate VMP1 expression by northern blotting after 24 h
of treatment (15). Differences in these results may be due
to the length of PMA treatment schedules or northern blot
sensitivity.
While PMA and androgen stimulation enhanced both
VMP1 and miR-21 messages, their genomic organization
clearly indicates that VMP1 and pri-miR-21 are regulated
by independent promoters. One potential difference could
be epigenetic regulation through the presence of CpG
islands or chromatin conformation. Previous studies of
the pri-miR-21 promoter region have not detected CpG
islands (18,34). However, Iorio et al. (35) did identify a
short, 300 bp and 50% GC-rich area upstream of the
miR-21 hairpin as a putative CpG island. This may
account for the elevated expression of miR-21 in divergent
models after 5-aza-20-deoxycitidine (5-AZA-CdR) treat-
ment (36,37). Here, we report that VMP1 also has a poten-
tial CpG island surrounding its TSS which is longer at
500 bp and is 55% GC rich (Supplementary Figure S5A).
To investigate the methylation potential of these regions we
performed bisulﬁte sequencing of genomic DNA from two
cell lines with low basal expression ofmiR-21, HEK293 and
HCT116. The results reveal that the previously identiﬁed
pri-miR-21 CpG island is commonly methylated in both
cell lines, while the larger VMP1 CpG island is not
methylated (Supplementary Figure S7). We then separately
treated these cells with the epigenetic modifying agents
5-AZA-CdR and MS-275. Quantitative RT-PCR of
pri-miR-21 (intron 11) as well as VMP1 (exons 10-11)
indicated both similar and differential responses of these
two genes following treatment (Figure 8). Speciﬁcally,
both VMP1 and pri-miR-21 were induced by 50-AZA-
CdR in HEK293 and HCT116 cells. These results suggest
that the pri-miR-21 CpG island may directly inﬂuence
expression of both pri-miR-21 and VMP1 transcripts,
although indirect regulation cannot be excluded. On the
other hand, the MS-275 histone deacetylase (HDAC)
inhibitor showed differential induction of VMP1 and
pri-miR-21 in HCT116 cells. In particular, VMP1 levels
were strongly induced by MS-275 treatment (Figure 8A),
while pri-miR-21 levels were only mildly affected (Figure
8B). Further studies are required to determine if these diver-
gent responses are due to direct epigenetic modiﬁcation
of VMP1 gene regulatory elements in these cells. Finally,
we evaluated whether the induced expression of VMP1–
miR-21 and pri-miR-21 correlated with elevated levels of
mature miR-21 (Figure 8C). Notably, a 3-fold increase in
both VMP1 and pri-miR-21 in HEK293 cells following
MS-275 treatment correlated with 6-fold increase in
mature miR-21. However, there are other examples where
VMP1 and pri-miR-21 expression did not correlate with
mature miR-21 levels, indicating that post-transcriptional
processing of VMP1 and pri-miR-21, such as polyadenyla-
tion or drosha cleavage, inﬂuenced the overall levels of
mature miR-21.
DISCUSSION
Since the discovery of miRNAs, a great amount of effort
has been devoted to the characterization of their primary
transcripts and promoters. Many studies have applied
pre-determined size limits in promoter-prediction studies,
for instance by examining a maximum distance of 100 kb
upstream the miRNA hairpin. This approach has favored
the discovery of more adjacent promoters and shorter
pri-miRNAs (15,34,38,39). Similarly, 50-RACE is biased
toward the discovery of shorter products because they
are more efﬁciently reverse transcribed and ampliﬁed. In
the case of miR-21, several groups have predicted or
identiﬁed promoters and TSSs within intron 10 or 11 of
VMP1 (15,17,18,34). In other studies, where distance from
the hairpins has not been as heavily weighed, the miR-21
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Figure 7. Phorbol ester mediated induction of pri-miR-21 and VMP1–miR-21. (A) Northern blot analysis of total RNA from HL-60 cells treated
with PMA (+) or vehicle () for 6 h. At the left, probes used for each blot and identifying letters for the transcripts are indicated. (B) Quantitative
RT-PCR analysis of HL-60 cells treated with PMA or vehicle. Relative induced expression of VMP1 and VMP1–miR-21 (exons 10-11), pri-miR-21
(intron 11) and an area surrounding miR-21 hairpin (miR-21) are normalized to actin. Note that VMP1 and VMP1–miR-21 are indistinguishable by
this quantitative RT-PCR analysis. Error bars represent standard deviations derived from two independent experiments measured per triplicate.
***P< 0.001 (Student’s t-test).
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promoter was hypothesized to be immediately upstream of
the VMP1 transcript (40). However, all reported human
VMP1 cDNAs and ESTs terminate before the miR-21
hairpin (Figure 4A). Only one human transcript contain-
ing the miR-21 hairpin, termed BC053563, is identiﬁable
in Genome Browser analysis. It is not clear why the pre-
dominant 4.3 kb pri-miR-21 (15) or the newly discovered
2.5 kb VMP1–miR-21 transcripts were not previously
identiﬁed in cDNA and EST libraries. It is possible that
oligo-dT bias predominantly identiﬁed VMP1 transcripts,
rather than pri-miR-21 transcripts, from this region. The
region between the 30-terminus of VMP1 and miR-21 is
also short and AT-rich, which may have hidden this
region from random priming. Cell-speciﬁc differences in
VMP1 polyadenylation could be also responsible for the
lack of VMP1–miR-21 detection. Further, Drosha
cleavage would have separated upstream VMP1 and
pri-miR-21 regions, keeping them from discovery. Here
we demonstrate that VMP1–miR-21 is readily detectable
in multiple cancer cell lines, especially when Drosha levels
are ﬁrst knocked down by siRNA treatment.
The overlapping nature of miR-21 and VMP1 has made
their transcripts difﬁcult to characterize. Here, we have
performed detailed northern blotting and gene-speciﬁc
quantiﬁcation studies to distinguish and enumerate the
predominant forms of miR-21 primary transcripts in
multiple human cell lines. Two predominant miR-21 tran-
scripts are notable, a larger transcript consistent with the
4.3 kb pri-miR-21 identiﬁed by Fujita et al. (15), and the
novel VMP1–miR-21 transcript. We did not detect any
band of compatible size to BC053563 or, alternatively,
to the similar transcript described by Cai et al. (12). This
may be expressed at levels below the detection sensitivity
of our northern blots. VMP1–miR-21 expression was
observed in several cell lines, with MCF-7 and DU-145
showing the highest expression in our study (Figure 2B).
Interestingly the ratio of pri-miR-21 to VMP1–miR-21 is
quite different among the cell lines, suggesting differential
regulation or stability. This is consistent with the initial
characterization of VMP1 transcripts in rat tissues.
Dusetti et al. (13) probed rat tissue northern blots with
the full-length VMP1 cDNA and found three bands of 3.5,
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6830 Nucleic Acids Research, 2012, Vol. 40, No. 14
 at Lleida Etsea Lib - U
54 on D
ecem
ber 11, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
2.7 and 1.9 kb. The larger bands are peculiar because the
cDNA was only 1.9 kb, but we suggest that this was likely
the 50-Drosha cleavage product of the pri-miR-21 tran-
script (band ‘a1’ in Figure 2A). In rats, the ratios of
these three bands were different in different tissues,
which the authors predicted to be due to differential
splicing (13). We predict that the differences in expression
were likely due to the differential regulation of VMP1 and
pri-miR-21 promoters and alternative polyadenylation.
VMP1, consisting of 12 exons, has at least 109 predicted
splicing variants by the ECgene database (41). However,
our northern blot studies with probes P1, P3, and P4
indicate that VMP1 is not signiﬁcantly alternatively
spliced, but rather that it encodes multiple transcripts
which are alternatively polyadenylated.
To truly function as a primary miRNA, the miR-21
hairpin must be released by Microprocessor cleavage. In
a number of assays we found inhibition of Drosha to sta-
bilize both pri-miR-21 as well as VMP1–miR-21 tran-
scripts, supporting that they are both substrates for the
Microprocessor complex. In the case of VMP1–miR-21,
which contains the coding region of VMP1, it is logical
that Microprocessor cleavage would reduce the level of
VMP1 message by leaving an unprotected 30-terminus.
In a model study by Cai et al. (12), the inclusion of
miR-30 in an artiﬁcial UTR of the ﬁreﬂy luciferase
reduced the activity of the enzyme by 2-fold or less.
These ratios are similar to the fold of VMP1 mRNA
induction observed in our Drosha inhibition study
(Figure 5). Our studies in the absence of new transcription
indicate that this increase can be due to both VMP1
mRNA transcript stability as well as efﬁciency of tran-
scription (Supplementary Figure S6). We predict that
miR-21 processing would correspondingly reduce VMP1
protein levels, but that the effect would likely be mild
because VMP1–miR-21 only accounts for a fraction of
the VMP1 coding transcripts. It should also be mentioned
that Drosha activity is not restricted to miRNA hairpins.
The RNase III enzyme can also negatively regulate
mRNAs by cleaving physiological loops contained
throughout the transcript. For example Drosha modulates
the levels of its partner, DGCR8, by cleaving the highly
conserved hairpins in its 50-UTR (42). This has been con-
ﬁrmed in mouse embryonic cells where several additional
Drosha-regulated mRNAs were identiﬁed (43). However,
our results support a conventional miRNA hairpin
cleavage of pri-miR-21 and VMP1–miR-21, rather than
internal cleavage, because Drosha siRNA did not have
dramatic effects on product sizes in northern blotting
(Figure 2B). In addition, RT-PCR detection of the
30-end of VMP1 was more efﬁcient when Drosha was
inhibited. Therefore, we believe that both pri-miR-21
and VMP1–miR-21 are direct sources for pre-miR-21
and mature miR-21 miRNA.
Mounting evidence suggests that, like pre-mRNA, the
processing of pri-miRNA is coupled to transcription
[reviewed in Ref. (44)]. For example, Pawlicki and Steitz
(7) reported that exogenously expressed pri-miRNAs,
without poly(A) signals, are retained at the transcription
site. Here we found that pri-miR-21 and VMP1–miR-21
utilized different poly(A) signals, despite containing
identical overlapping sequences. Speciﬁcally, the
pri-miR-21 poly(A) is several hundred base pairs down-
stream of the one used by VMP1–miR-21 (Figure 4). This
difference in polyadenylation may be related to
pre-mRNA processing, as the VMP1 coding gene is
spliced where the 4.3 kb pri-miR-21 is non-coding and is
not spliced. There may also be inﬂuence from promoter
structure and gene context. For instance, it has been
reported that transient expression of a pri-miRNA from
a miRNA promoter resulted in higher levels of Drosha
recruitment, increased retention on the DNA template
and enhanced processing of the pri-miRNA compared to
the same pri-miRNA driven by promoters such as
phosphoglycerate kinase, cytomegalovirus or U1 (45).
Therefore, several complex features may contribute to
the differential processing of VMP1–miR-21 and pri-
miR-21.
VMP1 and pri-miR-21 appear to have several common
mechanisms for gene expression. VMP1 was initially
identiﬁed as a stress-induced gene in acinar cells during
acute pancreatitis and in kidney after transient failure
(13). According to its observed function in stress para-
digms, enforced expression of VMP1 triggered cell death
accompanied by vacuolization. More recent studies
suggest that VMP1 participates in the autophagy
cascade (46–51) and that it is critical for autophagy in
metazoan organisms (52). Pri-miR-21 expression is also
associated with stress and inﬂammation, and its regulation
has been mapped speciﬁcally to interleukin-6 signaling
and STAT3 activation at the miPPR-21 promoter region
(17). In addition to inﬂammatory pathways, pri-miR-21
expression is directly induced by the AP-1 transcrip-
tion factors through three conserved elements within
miPPR-21 promoter region (15). Here, we found
that VMP1 was also stimulated by PMA (Figure 7A
and B). While the promoter of VMP1 has not yet been
annotated, visual inspection with the UCSC Genome
Browser ‘Human/rat/mouse conserved transcription
factor binding sites’ track indicated one AP-1 binding
site (TRANSFAC z-score of 2.01) within 1.5 kb of the
ﬁrst intron of VMP-1. Therefore, AP-1 may directly
induce VMP1. Finally, we previously reported that
pri-miR-21 is induced by androgens in prostate cancer
cells through direct AR binding of the miPPR-21
promoter (23). In Supplementary Figure S1A, we also
found VMP1 to be induced by androgens in four AR-
positive prostate cell lines. Therefore, there appear to be
several common and cancer associated regulatory
pathways which induce VMP1, VMP1–miR-21 and
pri-miR-21 expression.
It has been previously reported that miR-21 can be
induced through chromatin modifying agents (36,37). A
putative CpG island had been identiﬁed near the pri-miR-
21 promoter region (37). In addition, we identiﬁed a prom-
inent 500 bp CpG island within the predicted VMP1 regu-
latory region (Supplementary Figure S5). In our studies we
found that the previously identiﬁed pri-miR-21 CpG island
wasmethylated,while the longerVMP1CpG islandwas not
(Supplementary Figure S7). 5-Aza-CdR treatment
increased both VMP1 and pri-miR-21 expression levels.
On the other hand, HDAC inhibitor treatment enhanced
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VMP1, but not pri-miR-21, expression in HCT116 cells
(Figure 8). These results support that VMP1 and pri-miR-
21 are differentially regulated by independent promoters
and chromatin structure. However, elevated VMP1 expres-
sion did not always correlate with elevated mature miR-21
levels. This is likely due to alternative polyadenylation of
VMP1 transcripts. For example, inHCT116 andHeLa cells
pri-miR-21 and VMP1 are detected in the absence of
VMP1–miR-21 (Figure 2B). Recent transcriptome wide
RNA sequencing studies indicate that alternative poly-
adenylation events often differ among different tissue
types (53). Polyadenylation site selection is further altered
in proliferating and cancerous cells (54,55). Thus, VMP1
may be alternatively polyadenylated in different cell types
or in cancer, leading to gains or losses of mature miR-21
levels. Further studies are required to determine inﬂuence
and mechanisms of alternative polyadenylation on miR-21
expression in various tissues and cancer types.
In summary, we have provided new evidence that
miR-21 can be generated through two independently
regulated transcripts. One previously reported transcript,
pri-miR-21, is non-spliced and preferentially terminates at
the most distal poly(A) signal. The second transcript,
VMP1–miR-21, is a spliced and coding mRNA generated
through alternative polyadenylation of VMP1-initiated
transcripts. These two overlapping genes are induced
by common and independent transcriptional regulatory
pathways. Further characterization of the VMP1
promoter region and mechanisms of alternative polya-
denylation should provide new insights into the regulation
of the oncogenic miRNA, miR-21, in cancerous tissues.
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